Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDB5P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,386
Award facts
- Contract value 100% obligated
- $45,386.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,386.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 23, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pens. This is a non-set-aside, competitively awarded contract with an ultimate completion date of January 26, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide.
AmerisourceBergen's pharmaceutical supply capabilities encompass a broad portfolio including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The parent company, Cencora, Inc., holds an additional significant Indefinite Delivery Contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, demonstrating the company's substantial role in supporting federal medical procurement needs. The delivery order for Zepbound, a diabetes medication, exemplifies the type of critical pharmaceutical commodities supplied through these contract vehicles to support military treatment facilities and federal health systems globally.
Quick answers
Who was awarded contract SPE2DR26FDB5P?
SPE2DR26FDB5P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FDB5P worth?
The government has obligated $45,386 on SPE2DR26FDB5P.
Is contract SPE2DR26FDB5P an order under another contract?
Yes. SPE2DR26FDB5P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDB5P competed?
The extent of competition for SPE2DR26FDB5P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award